Ursocol 300mg

Ursodeoxycholic acid (UDCA) is a bile acid derivative that offers several therapeutic benefits, primarily in the management of liver-related conditions. One of its key features is its ability to dissolve cholesterol gallstones, particularly in patients who are not suitable candidates for surgical intervention or who wish to avoid surgery. UDCA works by reducing the secretion of cholesterol into bile and promoting the dissolution of cholesterol-rich gallstones, ultimately helping to prevent their formation and recurrence. Additionally, UDCA can improve liver function and reduce liver enzyme levels in certain liver diseases, such as primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC). By modulating bile acid composition and flow, UDCA helps alleviate cholestasis and inflammation, thereby slowing disease progression and improving overall liver health.

Furthermore, UDCA exhibits anti-inflammatory and cytoprotective properties, making it a valuable therapeutic agent in various gastrointestinal disorders. It can mitigate inflammation in the gastrointestinal tract, particularly in conditions such as inflammatory bowel disease (IBD) and non-alcoholic fatty liver disease (NAFLD). Additionally, UDCA has been studied for its potential role in preventing bile reflux gastritis and reducing the risk of gallstone formation following certain types of bariatric surgery. Its favorable safety profile and well-established efficacy make UDCA a versatile treatment option for a range of liver and gastrointestinal disorders, providing patients with symptomatic relief and potentially improving long-term outcomes.